A detailed history of Lpl Financial LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Lpl Financial LLC holds 13,111 shares of NBIX stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,111
Previous 12,328 6.35%
Holding current value
$1.64 Million
Previous $1.7 Million 11.08%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$114.58 - $153.15 $89,716 - $119,916
783 Added 6.35%
13,111 $1.51 Million
Q2 2024

Aug 07, 2024

SELL
$130.86 - $143.19 $30,359 - $33,220
-232 Reduced 1.85%
12,328 $1.7 Million
Q1 2024

May 10, 2024

BUY
$130.4 - $143.74 $356,383 - $392,841
2,733 Added 27.81%
12,560 $1.73 Million
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $1,378 - $1,725
13 Added 0.13%
9,827 $1.29 Million
Q3 2023

Nov 13, 2023

BUY
$94.02 - $117.1 $150,432 - $187,360
1,600 Added 19.48%
9,814 $1.1 Million
Q2 2023

Jul 31, 2023

BUY
$89.53 - $104.87 $1,880 - $2,202
21 Added 0.26%
8,214 $774,000
Q1 2023

May 10, 2023

SELL
$94.11 - $123.02 $283,835 - $371,028
-3,016 Reduced 26.91%
8,193 $829,000
Q4 2022

Feb 07, 2023

SELL
$106.72 - $127.06 $456,548 - $543,562
-4,278 Reduced 27.62%
11,209 $1.34 Million
Q3 2022

Nov 14, 2022

SELL
$92.03 - $107.81 $136,296 - $159,666
-1,481 Reduced 8.73%
15,487 $1.65 Million
Q2 2022

Aug 12, 2022

SELL
$75.79 - $100.07 $87,689 - $115,780
-1,157 Reduced 6.38%
16,968 $1.65 Million
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $94,040 - $123,063
-1,298 Reduced 6.68%
18,125 $1.7 Million
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $110,235 - $147,008
-1,384 Reduced 6.65%
19,423 $1.65 Million
Q3 2021

Nov 15, 2021

BUY
$86.18 - $99.03 $572,579 - $657,955
6,644 Added 46.91%
20,807 $2 Million
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $684,497 - $782,774
7,654 Added 117.59%
14,163 $1.38 Million
Q1 2021

May 14, 2021

SELL
$87.57 - $119.4 $178,204 - $242,979
-2,035 Reduced 23.82%
6,509 $633,000
Q4 2020

Feb 12, 2021

BUY
$86.91 - $108.33 $59,967 - $74,747
690 Added 8.79%
8,544 $819,000
Q3 2020

Nov 09, 2020

BUY
$96.16 - $135.15 $160,587 - $225,700
1,670 Added 27.01%
7,854 $755,000
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $32,844 - $50,318
386 Added 6.66%
6,184 $754,000
Q1 2020

May 14, 2020

SELL
$75.11 - $113.76 $15,097 - $22,865
-201 Reduced 3.35%
5,798 $502,000
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $226,895 - $309,941
2,614 Added 77.22%
5,999 $645,000
Q3 2019

Nov 13, 2019

SELL
$83.82 - $101.5 $18,188 - $22,025
-217 Reduced 6.02%
3,385 $305,000
Q2 2019

Aug 09, 2019

SELL
$72.24 - $91.27 $68,555 - $86,615
-949 Reduced 20.85%
3,602 $304,000
Q1 2019

May 08, 2019

BUY
$69.31 - $91.53 $45,536 - $60,135
657 Added 16.87%
4,551 $401,000
Q4 2018

Feb 07, 2019

BUY
$68.32 - $124.36 $266,038 - $484,257
3,894 New
3,894 $278,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.